Insight into the molecular mechanisms underlying enhanced gonadotropin hormone receptor activity in polycystic ovarian syndrome

被引：0
|
作者：
Owens, L. [1 ]
Lerner, A. [1 ]
Sposini, S. [1 ]
Christopoulos, G. [1 ]
Liyanage, M. [1 ]
Islam, R. [1 ]
Lavery, S. [1 ]
Tsui, V [1 ]
Hardy, K. [1 ]
Franks, S. [1 ]
Hanyaloglu, A. [1 ]
机构：
[1] Imperial Coll London, Inst Reprod & Dev Biol, London, England
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2016年 / 185卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OC5
引用
收藏
页码：370 / 370
页数：1
相关论文
共 50 条
  • [31] Mechanisms underlying episodic gonadotropin-releasing hormone secretion
    Moenter, SM
    DeFazio, RA
    Pitts, GR
    Nunemaker, CS
    FRONTIERS IN NEUROENDOCRINOLOGY, 2003, 24 (02) : 79 - 93
  • [32] ADRENAL AND OVARIAN-STEROID HORMONE RESPONSES TO GONADOTROPIN-RELEASING-HORMONE AGONIST TREATMENT IN POLYCYSTIC-OVARY-SYNDROME
    GONZALEZ, F
    HATALA, DA
    SPEROFF, L
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 165 (03) : 535 - 545
  • [33] Ultrasound-detected polycystic ovarian syndrome associated with depleted basal level but enhanced response of gonadotropin
    Imai, A
    Furui, T
    Tamaya, T
    JOURNAL OF MEDICINE, 1995, 26 (5-6) : 337 - 342
  • [34] Triggering ovulation with gonadotropin-releasing hormone agonist versus human chorionic gonadotropin in polycystic ovarian syndrome. A randomized trial
    Farag, Amr Hassaan
    El-deen, Mohamed Hassan Nasr
    Hassan, Rasha Mostafa
    MIDDLE EAST FERTILITY SOCIETY JOURNAL, 2015, 20 (04) : 217 - 223
  • [35] Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome
    Moore, Aleisha M.
    Prescott, Mel
    Marshall, Christopher J.
    Yip, Siew Hoong
    Campbell, Rebecca E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (02) : 596 - 601
  • [36] Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients
    Hosseini, Marzieh Agha
    Aleyasin, Ashraf
    Saeedi, Hojjatollah
    Mahdavi, Atossa
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2010, 36 (03) : 605 - 610
  • [37] PERSISTENCE OF HYPERINSULINEMIA IN POLYCYSTIC-OVARY-SYNDROME AFTER OVARIAN SUPPRESSION BY GONADOTROPIN-RELEASING-HORMONE AGONIST
    DALE, PO
    TANBO, T
    DJOSELAND, O
    JERVELL, J
    ABYHOLM, T
    ACTA ENDOCRINOLOGICA, 1992, 126 (02): : 132 - 136
  • [38] GONADOTROPIN-RELEASING-HORMONE AGONIST REDUCES THE MISCARRIAGE RATE FOR PREGNANCIES ACHIEVED IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
    HOMBURG, R
    LEVY, T
    BERKOVITZ, D
    FARCHI, J
    FELDBERG, D
    ASHKENAZI, J
    BENRAFAEL, Z
    FERTILITY AND STERILITY, 1993, 59 (03) : 527 - 531
  • [39] IS ABBERANT HIPPO SIGNALING THE UNDERLYING ETIOLOGY OF POLYCYSTIC OVARIAN SYNDROME?
    Maas, K.
    Mirabal, S.
    Penzias, A.
    Sweetnam, P. M.
    Eggan, K. C.
    Sakkas, D.
    FERTILITY AND STERILITY, 2016, 106 (03) : E251 - E252
  • [40] STIMULATING AUTOANTIBODIES DIRECTED TO THE GONADOTROPIN RELEASING HORMONE RECEPTOR ARE SENSITIVE AND SPECIFIC FOR POLYCYSTIC OVARY SYNDROME.
    Craig, L. B.
    Reynolds, A. C.
    Burks, H. R.
    Li, H.
    Yu, X.
    Aston, C. E.
    Elkosseifi, M.
    Kem, D. C.
    FERTILITY AND STERILITY, 2017, 108 (03) : E259 - E259
12345